Delivra Health Brands Inc. has surged by 15% in a single trading session, making waves in the TSXV.
In an impressive one-day performance, Delivra Health Brands Inc. (DHB.V) saw its stock price soar by 15%, closing at CA$0.12. This surge comes after positive financial results and growing sales for its popular products, Dream Water® and LivRelief™.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Delivra Health Brands Inc.
DHB.V
DHB.V
Delivra Health Brands Inc.
WealthAwesomeMarket cap
$3.44M
52W high
$0.37
52W low
$0.10
1W change
+10.00%
Beta
0.89
Analyst Price Targets
Based on analyst covering DHB
Wall Street analysts forecast DHB stock price to rise 381.8% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.53
+381.8% Upside
Current Price
C$0.11
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DHB's historical volatility
30-Day Vol
111.7%
Annualized
90-Day Vol
111.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.07 – C$0.15 |
| 60 trading days | C$0.10 | C$0.06 – C$0.17 |
| 90 trading days | C$0.09 | C$0.05 – C$0.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should take note of Delivra's recent sales growth and its potential for continued upward momentum in a competitive health market.
Delivra Health Brands Inc. sees a 15% stock increase in one day
With a market cap of CA$3.13 million, the stock's upward movement reflects investor optimism amid reported revenue growth.
Bull case
The company reported an 8% increase in Dream Water® sales and a 9% increase in LivRelief™ sales compared to the same quarter last year. This indicates strong consumer demand and effective product positioning, suggesting that Delivra is successfully meeting market needs.
Bear case
Despite the positive growth, Delivra Health Brands still operates at a loss, with a profit margin of -8.99%. Investors should remain cautious about the company's long-term profitability, as this could impact future performance.
Strong Sales Figures
Delivra Health Brands has reported an 8% growth in Dream Water® sales and a 9% increase in LivRelief™ sales compared to the same quarter last year. This growth signals a positive trend for the company, showcasing its ability to capture consumer interest and demand in the health and wellness sector.
Market Reaction
The stock's impressive 15% gain reflects investor confidence in Delivra's growth trajectory. With a market cap of CA$3.13 million, this upward movement may attract further investment as the company continues to report positive financial results. Investors should keep an eye on upcoming earnings reports for more insights into the company's performance.
Looking Ahead
While the recent surge is encouraging, investors should remain cautious due to the company's current profit margin of -8.99%. The path to profitability will be crucial for sustaining investor interest and ensuring long-term growth. For more details on Delivra Health Brands, check out their stock page here.
Advertisement
